Tag: Biotech

Zareh Zurabyan, head of the Americas division at eLabNext, joins us to discuss how the company has integrated generative AI workflows into their digital notebook solution for scientists. He addressed some of the main challenges hindering wider AI adoption in biotech, particularly privacy concerns related to data handling. We also explored Zareh’s journey to becoming an investor and the trends he’s most excited about in the biotech sector.

Dr. Lucy Abgaryan, the co-founder and CEO of GrittGene Therapeutics, a biotech company based in Los Angeles, California, joins us to discuss how her company is working to find treatments for Myotonic Dystrophy, a rare genetic disorder that causes progressive muscle loss and weakness. Lucy also shared with us her experience in trying to find opportunities to work with the local Armenian biotech industry.

This week on EVN Disrupt we are continuing our series of podcasts from the Science and Technology Convergence Conference. Once again, we have two guests on this week’s podcast. Our first guest is Ashot Papoyan, a biotech executive who is the Chief Operating Officer at Biosim and CEO of Elm Tree Research. Our second guest is Haig Eskandarian, a microbiologist at the University of California, San Francisco. With our two guests we spoke about experimental biology and commercializing science findings in the biotech industry.

Zareh Zurabyan, the head of the Americas division at eLabNext, a European biotech company, joins us to discuss problems the biotech industry is currently working to solve. Zareh describes who the different players in biotech ecosystems are and what trends he is seeing in the industry in 2022. We also discussed his efforts to mentor Armenian start-ups and his thoughts on Armenia’s biotech scene.

Academic programs around the world are not preparing enough bioinformaticians to deal with the exponential data growth we are observing. Armenia needs to catch up quickly.